Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

European stocks trade higher; UBS gains after completing Credit Suisse takeover

Published 06/12/2023, 02:08 AM
Updated 06/12/2023, 03:24 AM
© Reuters.

Investing.com - European stock markets drifted higher Monday, at the start of a week dominated by a series of key central bank meetings in the U.S., Asia and Europe.

At 03:20 ET (07:20 GMT), the DAX index in Germany traded 0.6% higher, the CAC 40 in France rose 0.5%, while the FTSE 100 in the U.K. traded 0.3% higher.

Central bank decisions to drive stock markets

European equities edged nervously higher Monday, with investors focusing on monetary decisions this week from three major central banks - the Federal Reserve, the European Central Bank and the Bank of Japan - given there is little in the way of major earnings or economic data due.

The Fed will be the first on show, with its two-day meeting concluding on Wednesday. 

The U.S. central bank is generally expected to pause its year-long tightening cycle, as officials assess the impact of the lifting interest rates to a 16-year high, but with consumer inflation data due on Tuesday there could still be a surprise.

After all, both the Reserve Bank of Australia and the Bank of Canada shocked the markets with interest rate hikes last week.

By contrast, there is more certainty with the other central bank decisions. The ECB has signaled another rate increase is coming on Thursday, while the BOJ is widely expected to stick to its ultra-loose monetary policy at the end of the week.

UBS completes takeover of Credit Suisse

In corporate news, UBS (SIX:UBSG) stock rose 0.8% after the lender announced Monday that it had formally completed the takeover of stricken rival Credit Suisse, creating a giant Swiss bank with a balance sheet of $1.6 trillion and greater muscle in wealth management.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Staying in Switzerland, Novartis (SIX:NOVN) stock rose 1.4% after the pharma giant announced earlier Monday plans to acquire U.S.-based Chinook Therapeutics (NASDAQ:KDNY) for $3.2 billion upfront.

Novo Nordisk (CSE:NOVOb) stock rose 0.7% after the Danish drugmaker announced plans to invest over $2B to expand a production facility in Denmark.

BioNTech (ETR:22UAy) is also in the spotlight as a court case is set to start in Germany, with a woman alleging damaging side effects from the biotech’s COVID-19 vaccine - a lawsuit that could have widespread repercussions.

Iran floats possibility of nuclear deal

Oil prices retreated Monday after Iran’s supreme leader said that Tehran was open to a deal with the West over its nuclear program, potentially flooding the market with additional supply if sanctions on Iranian crude exports are lifted. 

Ayatollah Ali Khamenei said that a deal was possible if Iran’s nuclear infrastructure was kept intact, something that wouldn’t sit easily with Western leaders. 

Both Tehran and Washington denied reports late last week that an interim nuclear deal was close. 

By 03:20 ET, U.S. crude futures traded 1.8% lower at $68.94 a barrel, while the Brent contract dropped 1.7% to $73.53. 

Additionally, gold futures fell 0.2% to $1,973.20/oz, while EUR/USD traded 0.1% higher at 1.0753.

Latest comments

VIX is sitting near the 5-year baseline, that let's you know all that you need prior to Fed. When VIX is up it means they plan to pump the market, and when VIX is low the plan to dump the market. P/E's are already at astronomical levels and interest rates are likely to end up at 7% going into 2024 elections.
Yes...go higher.....let every stocks rebound.....higher better.....no worries about inflation and recession........
so then everyone gonna shorting more confidently
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.